NorthWest Biotherapeutics Inc (NWBO)

[jfr1611]

Good morning Alphapuppy.
First I want to thank you for your valuable comments over the years.
Second, if I may, I would like to say that the waiting period has NOTHING to do with the quality of the results.
I think the company has been very open on how they will report the results: peer review manuscripts, TLD & scientific publication at the same time.
There’s more than 90 persons who worked on the study in 4 different countries. To collect the signatures is one of the reasons why it’s taking so long. Each of them have to review the manuscript and approve it. You can’t do it over a weekend.
The company is also unblinded. If negative, they would have been forced to announced it to the market. So, I’m not concerned, the trial has not failed, it’s a success.

We’re all impatient to see the big press release but I think Linda Powers is checking and covering every single piece of the puzzle. She knows the short sellers (in particular Adam F) are waiting to jump on her throat is she makes a mistake.
She has no room for disappointment.

That way, once the peer review manuscripts, TLD & scientific publication are out, nobody can challenge the results.